Clinical ResearchEmerging Trends in Financing of Adult Heart Transplantation in the United States
Graphical abstract
Key Words
Abbreviations and Acronyms
Cited by (0)
The contents are the responsibility of the authors alone and do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Supported by Health Resources and Services Administration contract 234-2005-37011C. Dr. Vaduganathan is supported by the KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst, Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, U.S. National Institutes of Health award KL2 TR002542); and serves on advisory boards for Bayer AG and Baxter Healthcare. Dr. Stehlik consults for Medtronic. Dr. Mehra consults for Abbott, Medtronic, Janssen, Mesoblast, NupulseCV, Bayer, and Portola. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- ∗
Drs. DeFilippis and Vaduganathan contributed equally to this work and are joint first authors.